MIF and primary progressive multiple sclerosis: In our previous study, we showed that increased MIF levels are associated with clinical disease activity in RRMS [26, 35], while increased levels of sTNF-α and sFas in sera in PPMS indicate the presence of inflammatory activity in this subtype [26].